Guangzhou Manjing Biomedicine Technology Co., Ltd

This study tests a new drug called NT-88 in 60 people with chronic heart failure where the heart's pumping ability is mildly reduced. The main goal is to check safety and side effects. Researchers will also measure changes in heart function, symptoms, and blood markers to see if …